Ribbon Biolabs
  • About
  • DNA Synthesis
  • Careers
  • Investors
  • Contact
Select Page
Ribbon Biolabs Reaches Key Milestone with Automation of InfiniSynth™ Platform for Commercial-scale, Unlimited Length DNA Synthesis

Ribbon Biolabs Reaches Key Milestone with Automation of InfiniSynth™ Platform for Commercial-scale, Unlimited Length DNA Synthesis

by Gabi Schaller | Dec 20, 2022 | News

December 20, 2022 – VIENNA, AUSTRIA: Ribbon Biolabs, the DNA synthesis company, today announced the successful implementation of their innovative InfiniSynth™ platform for the automated assembly of sequence-agnostic and long DNA. Ribbon Biolabs achieved this...
Ribbon Biolabs Raises 18 M EUR Series A Financing Enabling Commercial Scale Production Facilities and US Expansion for DNA Synthesis Technology

Ribbon Biolabs Raises 18 M EUR Series A Financing Enabling Commercial Scale Production Facilities and US Expansion for DNA Synthesis Technology

by Gabi Schaller | Jan 31, 2022 | News

January 31, 2022, VIENNA, AUSTRIA: Ribbon Biolabs, the DNA synthesis company, today announced the successful close of EUR 18 million in its Series A funding round from a consortium of European and US investors led by Hadean Ventures and with participation from...

We are hiring

  • Team Assistant 
  • Computational Biology Developer
  • Human Capital Manager
  • Lab Technician 
  • Lab Manager 
  • Student Intern 

Get in contact

Ribbon Biolabs GmbH
Viehmarktgasse 1B/EG
1030 Vienna | Austria
Email

Laboratory

Plöcking 1, IST Park
3400 Klosterneuburg

  • Twitter
  • RSS
© Ribbon Biolabs GmbH | Imprint | Data Protection Policy | website by indeco.cc